Michael Braden, M.D.
NPI 1043247455 · Dermatology Physician · Comfort, TX
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1043247455
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- H0203 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
3,328 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,419 | $6 |
| Destruction of Precancer Skin Growth, 15 Or More Growths17004 | 354 | $158 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 353 | $55 |
| Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212 | 323 | $54 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 235 | $87 |
| Destruction of Skin Growth, 1-14 Growths17110 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Clobetasol Propionate | 82 | 43 |
| Doxycycline Hyclate | 63 | 23 |
| Triamcinolone Acetonide | 43 | 27 |
| Metronidazole | 31 | 16 |
| Prednisone | 24 | 12 |
| Mometasone Furoate | 22 | 14 |
| Mupirocin | 20 | 14 |
| Hydrocortisone Valerate | 19 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-06-28
- Last updated
- 2020-12-18
- Certified
- 2020-12-15
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.